Stockscreener 앱 받기
65.37
3.73%
2.35
Ptc Therapeutics Inc 주식(PTCT)의 최신 뉴스
Will PTC Therapeutics Inc. rebound enough to break evenVolume Spike & Precise Buy Zone Identification - newser.com
Real time breakdown of PTC Therapeutics Inc. stock performanceBull Run & Free Safe Entry Trade Signal Reports - newser.com
Why PTC Therapeutics Inc. (BH3) stock could outperform next yearTrade Risk Report & Weekly Top Gainers Trade List - newser.com
Evaluating PTC Therapeutics Inc. with trendline analysisWeekly Stock Report & Low Risk High Win Rate Stock Picks - newser.com
Is PTC Therapeutics Inc. (BH3) stock among top earnings playsBear Alert & Low Risk High Reward Trade Ideas - newser.com
Will PTC Therapeutics Inc. (BH3) stock outperform energy sector in 20252025 Macro Impact & Consistent Income Trade Ideas - newser.com
Using AI based signals to follow PTC Therapeutics Inc.2025 Historical Comparison & Reliable Intraday Trade Plans - newser.com
Ptc Therapeutics stock hits 52-week high at 63.33 USD By Investing.com - Investing.com Nigeria
Ptc Therapeutics stock hits 52-week high at 63.33 USD - Investing.com India
19,475 Stock Options, 39,060 RSUs: PTC Therapeutics Awards Major Inducement Grants to New Employees - Stock Titan
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PR Newswire
PTC Therapeutics to Participate at Upcoming Investor Conferences - GuruFocus
PTC Therapeutics, Inc. (NASDAQ:PTCT) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
Larimar Proceeding Toward Accelerated Approval Filing In Friedreich’s Ataxia - insights.citeline.com
PTC Therapeutics says Duchenne drug Translarna is no longer authorized in EU - MSN
How to build a custom watchlist for PTC Therapeutics Inc.Options Play & AI Powered Market Entry Strategies - newser.com
PTC Therapeutics (PTCT): Assessing Valuation After New Huntington’s Data Shifts Competitive Landscape and Investor Sentiment - Yahoo Finance
Is PTC Therapeutics Inc a good long term investmentShort-Term Trading Alerts & Small Investment Portfolio Growth - earlytimes.in
PTC Therapeutics Inc Stock Analysis and ForecastGlobal Market Influence & Market Crushing Stock Picks - earlytimes.in
PTC Therapeutics Hits New 52-Week High of $63.19, Up 67% Yearly - Markets Mojo
PTC's utreloxastat fails Phase 2 clinical study for ALS - MSN
PTC Therapeutics (PTCT) Faces Pressure Following Compelling uniQ - GuruFocus
PTCT Shares Decline Amid Early Market Activity - GuruFocus
Strs Ohio Takes Position in PTC Therapeutics, Inc. $PTCT - MarketBeat
PTC Therapeutics (NASDAQ:PTCT) Reaches New 1-Year HighTime to Buy? - MarketBeat
Financiere des Professionnels Fonds d investissement inc. Makes New $284,000 Investment in PTC Therapeutics, Inc. $PTCT - MarketBeat
Financiere des Professionnels Fonds d investissement inc. Buys Shares of 5,821 PTC Therapeutics, Inc. $PTCT - MarketBeat
CHMP maintains negative opinion on PTC Therapeutics' DMD treatment - MSN
PTC Therapeutics, Inc. $PTCT Shares Acquired by Assenagon Asset Management S.A. - MarketBeat
Harbor Capital Advisors Inc. Buys 8,042 Shares of PTC Therapeutics, Inc. $PTCT - MarketBeat
PTC Therapeutics (NASDAQ:PTCT) Director Sells $934,447.50 in Stock - MarketBeat
Intech Investment Management LLC Has $2 Million Stake in PTC Therapeutics, Inc. $PTCT - MarketBeat
Can PTC Therapeutics Inc expand into new markets2025 Biggest Moves & Community Shared Stock Ideas - khodrobank.com
2.68%
0.38%
자본화:
|
볼륨(24시간):